However, these compounds are still in preclinical stages for HCC treatment.271–273 For example, WP1066 has been demonstrated to inhibit MMPs and counteract the activity of UCK2, which suppressed the migration and invasion abilities of HCC cell lines.274. This evidence concerns the gene UCK2 and hepatocellular carcinoma.